Gastric Transitional Zones, Areas whereHelicobacterTreatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model
Open Access
- 1 July 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (7), 2249-2255
- https://doi.org/10.1128/aac.47.7.2249-2255.2003
Abstract
Current combination therapies cure Helicobacter pylori infection in 75 to 85% of cases. However, many treatment failures are not explained by antibiotic resistance. Our goal was to explore treatment failures under in vivo conditions by using the H. pylori Sydney strain (SS1) mouse model. Mice infected with H. pylori (SS1) were treated with monotherapies or combination therapies used in human trials. Bacterial levels and distribution of organisms within the stomach were assessed 24 h after treatment to determine clearance and location of treatment failures and 29 days after treatment to determine cure rates. Except for treatment with metronidazole, mono- and dual therapies did not cure infection but resulted in decreases in bacterial levels and differences in distribution within the stomach. In cases of treatment failure when clarithromycin was used, omeprazole and dual therapy with omeprazole and amoxicillin resulted in organisms being cleared from the antrum, but organisms remained in the antrum-body transitional zone. The triple therapies of OMC and bismuth subcitrate, metronidazole, and tetracycline were successful in eradicating infection. Except for metronidazole monotherapy and triple therapy with OAC, there was good correlation between the Sydney strain mouse model and humans with respect to the success of antimicrobial therapy. The antrum-body transitional zone was identified as a sanctuary site in treatment failure. This could result from antimicrobial agents not functioning effectively at this site or bacteria in this location expressing products that protect them against antimicrobial agents. This is the first demonstration of a possible sanctuary site as a reason for failure of therapy.Keywords
This publication has 40 references indexed in Scilit:
- The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infectionJournal of Antimicrobial Chemotherapy, 1997
- Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment ofHelicobacter pyloriDigestive Diseases and Sciences, 1996
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juiceGastroenterology, 1996
- The importance of local acid production in the distribution of Helicobacter felis in the mouse stomachGastroenterology, 1995
- Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine.Gut, 1995
- Rapid eradication of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1995
- Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.Gut, 1995
- Use of a Mouse Model to Examine Anti-Helicobacter pylori AgentsScandinavian Journal of Gastroenterology, 1991
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989